FDA grants orphan status to two Lux products

Article

The FDA has granted orphan drug designation to two of Lux Bioscience's investigational therapies.

Recent Videos
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Brent Kramer, MD, of Vance Thompson Vision speaks at the 2024 AAO meeting
Related Content
A screenshot of the United States Food and Drug Administration (FDA) web page. US FDA Complete Response Letter CRL concept. Image credit: ©Jarretera – stock.adobe.com

US FDA issues second Complete Response Letter for dry eye drug reproxalap (Aldeyra Therapeutics)

Martin David Harp
April 3rd 2025
Article

Aldeyra previously received a CRL for its initial New Drug Application for reproxalap in November 2023

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
A woman with myopia holds a pair of glasses at a distance and looks through the vision-correcting lens. Paediatric myopia control concept. Image credit: ©Chanintorn.v – stock.adobe.com

French OPHTAMYOP study reveals trends in myopia control

Dominique Bremond-Gignac, MD, PhD, FEBO
April 2nd 2025
Article

How studies into myopia management can increase access to vision care

An image of the European Medicines Agency (EMA) headquarters to accompany a CHMP opinion. Image credit: ©Lubo Ivanko – stock.adobe.com

EMA grants positive CHMP opinion for low-dose atropine SYD-101 (Ryjunea, Sydnexis)

Hattie Hayes
April 1st 2025
Article

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression

A close-up of a doctor's face. The doctor wears PPE including a mask and safety goggles. Oncology and ophthalmology concept image. Image credit: ©H_Ko – stock.adobe.com

New study investigates ocular involvement in multiple myeloma

Lynda Charters
April 1st 2025
Article

Hematologists and ophthalmologists could work together for earlier diagnoses, research findings indicate

An image of boxing gloves in a ring, hanging over an open flame. ©Image by Jennifer Toomey / MJH Life Sciences using AI

Up for debate: Clinicians take on hot topics at the Congress on Controversies in Ophthalmology

Hattie Hayes;Anat Loewenstein, MD;Baruch Kuppermann, MD, PhD
March 31st 2025
Article

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

© 2025 MJH Life Sciences

All rights reserved.